- Filed
- Feb 20, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Feb 17, 2025 | 38.3M sh |
| Shares Diluted | FY 2024 · Oct 31, 2024 | 37.28M sh |
| Shares Diluted | FY 2024 · Oct 31, 2023 | 36.53M sh |
| Eps Basic | FY 2024 · Oct 31, 2024 | $0.00 |
| Eps Basic | FY 2024 · Oct 31, 2023 | −$0.01 |
| Capex | FY 2024 · Oct 31, 2023 | $20.59K |
| Operating Cash Flow | FY 2024 · Oct 31, 2023 | −$209.49K |
| Stockholders Equity | FY 2024 · Oct 31, 2023 | $1.11M |
| Current Liabilities | FY 2024 · Oct 31, 2023 | $350.56K |
| Total Liabilities | FY 2024 · Oct 31, 2023 | $394.99K |
| Current Assets | FY 2024 · Oct 31, 2023 | $819K |
| Total Assets | FY 2024 · Oct 31, 2023 | $1.5M |
| Eps Diluted | FY 2024 · Oct 31, 2023 | −$0.01 |
| Sga Expense | FY 2024 · Oct 31, 2023 | $464.07K |
| Net Income | FY 2024 · Oct 31, 2023 | −$301.38K |
| Operating Income restated | FY 2024 · Oct 31, 2023 | −$248.09K |
| Revenue | FY 2024 · Oct 31, 2023 | $347.76K |